Skip to content
Biodatica
Start free

Investigator

Elke Lipka

TSRL, INC. · funded by NIAID, NIDDK

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$3.1M

Summed across those awards.

First award
Aug 3, 2017

Latest Aug 16, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

  • TSRL, INC.

    ImmunologyGrant-only

    Momentum in another area
  • TSRL, INC.

    ImmunologyGrant-only

    Momentum in another area

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu

    $1000k

    Aug 16, 2024NIAIDTSRL, INC.NIH RePORTER · 11171506 (opens the source filing in a new tab)

  2. R44

    Microneedle delivery of Trospium Chloride optimized for improved tolerance and patient outcomes in overactive bladder disease

    $1.1M

    Sep 19, 2022NIDDKTSRL, INC.NIH RePORTER · 11180658 (opens the source filing in a new tab)

  3. R44

    Development of MRS-2541, a methionyl-tRNA synthetase inhibitor, for Gram positive bacterial infections.

    $1000k

    Aug 3, 2017NIAIDTSRL, INC.NIH RePORTER · 11047695 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources